Clinical characteristics and mean carotid artery IMT in type 2 diabetic patients and control subjects
| . | Type 2 diabetic patients (n = 87) . | . | Control subjects (n = 82) . | . | P value . | ||
|---|---|---|---|---|---|---|---|
| . | Male . | Female . | Male . | Female . | . | ||
| n | 53 | 34 | 45 | 37 | 0.43 | ||
| Age (years) | 59 ± 9 | 56 ± 8 | 58 ± 10 | 53 ± 7* | 0.15 | ||
| Carotid IMT (mm) | 0.91 ± 0.19 | 0.81 ± 0.20* | 0.86 ± 0.15 | 0.77 ± 0.12* | 0.025 | ||
| BMI (kg/m2) | 27.9 ± 4.4 | 30.7 ± 5.6* | 26.1 ± 3.3 | 25.1 ± 3.9 | <0.001 | ||
| Waist circumference (cm) | 102 ± 13 | 99 ± 14 | 94 ± 10 | 81 ± 12† | <0.001 | ||
| Systolic blood pressure (mmHg) | 141 ± 18 | 146 ± 20 | 132 ± 16 | 132 ± 21 | <0.001 | ||
| Diastolic blood pressure (mmHg) | 86 ± 9 | 88 ± 8 | 84 ± 9 | 81 ± 12 | 0.003 | ||
| Pulse pressure (mmHg) | 55 ± 16 | 58 ± 18 | 48 ± 11 | 51 ± 17 | 0.005 | ||
| Glucose (mmol/l) | 8.4 ± 1.8 | 9.4 ± 2.7 | 5.8 ± 0.7 | 5.5 ± 0.7* | <0.001 | ||
| HbA1c (%) | 6.7 ± 0.9 | 6.8 ± 1.1 | 5.4 ± 0.4 | 5.3 ± 0.4 | <0.001 | ||
| . | Type 2 diabetic patients (n = 87) . | . | Control subjects (n = 82) . | . | P value . | ||
|---|---|---|---|---|---|---|---|
| . | Male . | Female . | Male . | Female . | . | ||
| n | 53 | 34 | 45 | 37 | 0.43 | ||
| Age (years) | 59 ± 9 | 56 ± 8 | 58 ± 10 | 53 ± 7* | 0.15 | ||
| Carotid IMT (mm) | 0.91 ± 0.19 | 0.81 ± 0.20* | 0.86 ± 0.15 | 0.77 ± 0.12* | 0.025 | ||
| BMI (kg/m2) | 27.9 ± 4.4 | 30.7 ± 5.6* | 26.1 ± 3.3 | 25.1 ± 3.9 | <0.001 | ||
| Waist circumference (cm) | 102 ± 13 | 99 ± 14 | 94 ± 10 | 81 ± 12† | <0.001 | ||
| Systolic blood pressure (mmHg) | 141 ± 18 | 146 ± 20 | 132 ± 16 | 132 ± 21 | <0.001 | ||
| Diastolic blood pressure (mmHg) | 86 ± 9 | 88 ± 8 | 84 ± 9 | 81 ± 12 | 0.003 | ||
| Pulse pressure (mmHg) | 55 ± 16 | 58 ± 18 | 48 ± 11 | 51 ± 17 | 0.005 | ||
| Glucose (mmol/l) | 8.4 ± 1.8 | 9.4 ± 2.7 | 5.8 ± 0.7 | 5.5 ± 0.7* | <0.001 | ||
| HbA1c (%) | 6.7 ± 0.9 | 6.8 ± 1.1 | 5.4 ± 0.4 | 5.3 ± 0.4 | <0.001 | ||
Data are means ± SD. P values for the difference between type 2 diabetic patients (male and female subjects combined) and control subjects (male and female subjects combined) are shown. Within-group difference between male and female subjects:
P < 0.05,
P < 0.001.